Related Experiment Video
Updated: Jul 25, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
Comparison of four HTLV-I and HTLV-I + II ELISAs
H Vrielink1, H Reesink, M Habibuw
1Red Cross Blood Bank Amsterdam, Amsterdam, the Netherlands. BLBADAM@COMPUSERV.COM
Four enzyme-linked immunosorbent assays (ELISAs) for Human T-lymphotropic virus (HTLV-I and HTLV-II) screening demonstrated excellent sensitivity and specificity. These validated HTLV-I + II ELISAs are suitable for blood donor screening.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Mandatory screening for Human T-lymphotropic virus (HTLV-I and HTLV-II) is implemented in various countries.
- Accurate diagnostic assays are crucial for effective blood donor screening.
Purpose of the Study:
- To evaluate the diagnostic performance of four commercially available anti-HTLV-I + II enzyme-linked immunosorbent assays (ELISAs).
- To compare the sensitivity and specificity of Abbott, Murex, Organon Teknika, and Ortho ELISAs.
Main Methods:
- Utilized panels of known HTLV-I and HTLV-II positive samples, diluted samples, and sera from first-time blood donors (n=1,055).
- Assessed sensitivity and specificity of four anti-HTLV-I + II ELISAs using probit analysis for diluted samples.
Main Results:
- All four ELISAs achieved 100% sensitivity for HTLV-I and HTLV-II positive samples.
- Murex assay exhibited the highest analytical sensitivity in diluted samples.
- Murex, Organon Teknika, and Ortho ELISAs demonstrated 100% specificity in first-time donor samples; Abbott showed 99.7% specificity.
Conclusions:
- The evaluated anti-HTLV-I + II ELISAs are appropriate and effective for blood donor screening.
- The study confirms the reliability of these assays in detecting HTLV infections.
More Related Videos
06:34An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
07:24Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection
Published on: October 29, 2020